TrademarkDir
IPSEN INNOVATION FOR PATIENT CARE
DEAD

Serial Number

88373847

Owner

IPSEN S.A.

Attorney

Ben Natter & William S. Frommer

Filing Date

Apr 5, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IPSEN INNOVATION FOR PATIENT CARE Trademark

Serial Number: 88373847

IPSEN INNOVATION FOR PATIENT CARE is a trademark filed by IPSEN S.A. on April 5, 2019. The trademark is classified under Class 1 (Chemicals). The application is currently no longer active.

Owner Contact Info

IPSEN S.A. (46 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 03

Trademark Details

Filing Date

April 5, 2019

Registration Date

Not Registered

Published for Opposition

October 1, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Dec 19, 2022 MAB5
ABANDONMENT - AFTER PUBLICATION
Dec 19, 2022 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Dec 16, 2022 EXAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2022 EXRA
SOU EXTENSION 5 GRANTED
May 16, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 16, 2022 AITU
SOU EXTENSION 5 FILED
May 10, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
May 10, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jan 20, 2022 EWOR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 6, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 30, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 30, 2021 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 30, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2021 EXRA
SOU EXTENSION 4 GRANTED
Nov 5, 2021 EX4G
SOU EXTENSION 4 FILED
Nov 5, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 5, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2021 EXRA
SOU EXTENSION 3 GRANTED
Mar 31, 2021 EX3G
SOU EXTENSION 3 FILED
Mar 31, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 31, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2020 EXRA
SOU EXTENSION 2 GRANTED
Oct 28, 2020 EX2G
SOU EXTENSION 2 FILED
Oct 28, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 28, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2020 EXRA
SOU EXTENSION 1 GRANTED
Apr 7, 2020 EX1G
SOU EXTENSION 1 FILED
Apr 7, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 7, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2019 XAEC
ASSIGNED TO LIE
Aug 29, 2019 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 29, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 29, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 29, 2019 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 25, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2019 NWOS
NEW APPLICATION ENTERED
Apr 9, 2019 NWAP

Related Trademarks

More from this Owner

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE